Setipiprant Hair Loss - Is This A Breakthrough?

The Truth About Hair Loss -    • Hair Loss Industry Exposed! - How I regrew...  

In this article we go through setipiprant for hair loss - is this the 2019 breakthrough we've been looking for? We go through how it helps hair loss, side effects, and how it compares to minoxidil etc.

Full transcript:

Did you know that a new pathway for hair loss was discovered in 2012? This new pathway could mean there’s more to hair loss than we currently understand, and that new drugs can be useful in regrowth.

In this post, I’ll introduce you to a possible future hair loss treatment: setipiprant. You’ll learn how the drug works, as well as:

How clinical trials work, and where the drug currently is in the process.
The possible side effects associated with use.
The difference between oral and topical setipiprant, and the pros/cons of each.
How setipiprant compares to finasteride, and whether the drugs can be used together.
Of course, I’ll also share with you the natural alternatives to setipiprant that I recommend. These alternatives have been used by myself and many others with positive results.

And leave us a comment at the bottom of this article if you have any questions on this topic.

What is Setipiprant?
Setipiprant is an oral drug that’s currently being tested for use as a hair loss treatment. It was initially developed as a treatment for allergic rhinitis, but recent hair loss-related discoveries have made it a better candidate for hair loss reversal.

How Does It Work?
In short, setipiprant is an antagonist of the prostaglandin D2 receptor 2 (DP2). This receptor is responsible for bonding with and responding to certain prostaglandins, particularly PGD2. This prostaglandin has been linked to various pathological responses, including those linked to allergies, asthma, and inflammation.

For Allergies/Asthma
As setipiprant is believed to interfere with the receptors known to contribute to allergies/allergic responses, the drug was first tested on allergies and asthma.

In clinical trials, the drug performed quite well in the treatment of allergen-induced airway responses in asthmatic patients. It was also well tolerated by participants. However, its results were similar to those of drugs already on the market, so further trials were discontinued.

For Hair Loss
In 2012, researchers discovered a link between the PGD2 receptor and hair loss. More specifically, this receptor is seen at high levels in the scalps of men diagnosed with Androgenetic Alopecia (AGA).

AGA (Male-Pattern Baldness) is the most common cause of hair loss in men, though it’s also seen in women (Female Pattern Hair Loss).

-------------------------------

Disclaimer
This video is for educational purposes only and is not intended to treat, diagnose or cure any disease